iRND3 is a 501c3, non-profit research organization that conducts pre-clinical drug discovery research to help discover medicines for rare and neglected diseases.
iRND3 looks to satisfy its charitable mission through the collaborative discovery of medicines for rare and neglected diseases.
iRND3 has a well equipped lab in Mountain View, CA
iRND3 works to fund its mission through grants, donations and fee for service research.
iRND3's current disease focus is on trypanosome diseases and rare cancers.
iRND3's technical expertise is in the areas of drug discovery screening strategies, optimal molecule mechanism of action (MMOAs), binding kinetics, enzymology and assay development.